Attitudes among nurses in Sweden and factors for their reporting of adverse drug reactions
2011 (English)In: Abstracts 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Hyatt Regency Chicago: Chicago, Illinois, USA August 14–17, 2011, Wiley , 2011, Vol. 20, S202-S203 p.Conference paper (Refereed)
Background: Adverse drug reactions (ADRs) is a common cause for hospitalization and death. Spontaneous reporting of ADRs remains as one of the cornerstones in post marketing drug safety surveillance. In March 2007 the Medical Product Agency (MPA) in Sweden decided to also accept reports of suspected ADRs from all nurses.
Objectives: This study was designed to investigate attitudes and factors for reporting adverse drug reactions (ADRs) from nurses within the health care system in Sweden.
Methods: A questionnaire was distributed to 753 randomly selected nurses in Sweden.
Results: The most important factors in their decision to report as suspected ADRs were the severity, if the drug was newly approved and if the reaction were unusual. The nurses with a shorter professional experience responded to a higher degree than their colleagues that they made other priorities, did not have the time or where unaware/uncertain what and how to report. Almost two - thirds of the responders assessed that they had insufficient pharmacological knowledge. A vast majority (84%) of the responders would prefer a possibility to report a suspected ADR using a web - based formula.
Conclusions: Nurses in Sweden have a fairly good knowledge about the existing rules for reporting. However, there is room for improvement in some areas. Further education and information is needed.
Place, publisher, year, edition, pages
Wiley , 2011. Vol. 20, S202-S203 p.
, Pharmacoepidemiology and Drug Safety, ISSN 1053-8569 ; Vol. 20 Suppl. 1
Pharmacology and Toxicology
IdentifiersURN: urn:nbn:se:umu:diva-47915DOI: 10.1002/pds.2206ISI: 000294946600448OAI: oai:DiVA.org:umu-47915DiVA: diva2:445577
27th International Conference on Pharmacoepidemiology & Therapeutic Risk ManagementHyatt Regency Chicago, Chicago, Illinois, USA August 14–17, 2011